Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
721
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
24 May 2026 10:20
KRX Foreign Holding Weekly (May 22nd): Samsung Electronics, SK Hynix, Hyundai Motor, Mobis
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, Hyundai Motor,...
Ke Yan, CFA, FRM
Follow
130 Views
Share
bullish
•
Cross Asset Strategy
•
27 Nov 2018 05:23
EM Health Care:Â Late Cycle Rotation
Emerging Market Health Care allocations sit towards the lower end of their 7-year range. Current levels are off their 2015 highs by a margin, with...
Steven Holden
Follow
475 Views
Share
bearish
•
Thematic (Sector/Industry)
•
31 Oct 2018 21:23
Korea Stock Market Monthly Recap #30 (October 2018)
The Korean stock market fell sharply in October and KOSPI is down 13% this month. Nikkei is down 9% and S&P 500 is down 8% this month as well....
Douglas Kim
Follow
699 Views
Share
bullish
•
Thematic (Sector/Industry)
•
29 Oct 2018 13:52
Smartkarma’s Week That Was in JP/​​​​KR: Market Turbulence 10 Years After 2008, Coway, & Celltrion
The Korean and Japanese stock markets have fallen sharply in October. Nikkei is down 12% and KOSPI is down 14% in October. It has been 10 years...
Douglas Kim
Follow
499 Views
Share
bullish
•
Thematic (Sector/Industry)
•
03 Jul 2018 10:16
Japan & Korea @Smartkarma: Sharp, Activist in Korea, Alpine AGM & Zozo
Sharp offering update: C pref conversion going through Mio Kato, CFA provides an update on the Sharp offering. Sharp Corp (6753 JP) cancelled its...
Sanghyun Park
Follow
419 Views
Share
First
Previous
22
23
24
25
26
27
28
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x